Provided by Tiger Trade Technology Pte. Ltd.

Trendlines

0.051
0.000
Volume:58.90K
Turnover:3.00K
Market Cap:80.17M
PE:7.25
High:0.051
Open:0.051
Low:0.051
Close:0.051
52wk High:0.084
52wk Low:0.030
Shares:1.57B
Float Shares:958.00M
Volume Ratio:0.13
T/O Rate:0.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.007
EPS(LYR):0.002
ROE:9.62%
ROA:5.39%
PB:0.74
PE(LYR):24.29

Loading ...

Trendlines Group Ltd - Lh and Trendlines Investment in Portfolio Company

THOMSON REUTERS
·
Jul 01

Trendlines Says Lh-related Firms Invest up to USD 195,000 in Proarc SAFE Round

Reuters
·
Jul 01

Market Adjustments and Shifting Dynamics: Focusing on Trends and Categorical Management

Deep News
·
Jun 07

Trendlines Portfolio Company Closes $24 Million Series B Financing

MT Newswires
·
May 28

Trendlines portfolio company Phytolon closes US$ 23.6 million Series B financing

Reuters
·
May 28

Trendlines-backed Phytolon raises $23.6 million in Series B funding round

Reuters
·
May 26

Trendlines grants CEO Haim Brosh 18 million RSUs under share incentive plan

Reuters
·
May 21

Trendlines gets SGX nod to list shares issued under RSU incentive plan

Reuters
·
May 21

Trendlines Group's ElastiMed Expands Medical Wearables to US Market; Shares Drop 2%

MT Newswires
·
May 19

BRIEF-Trendlines Group Says Elastimed Enters Strategic U.S. Distribution Agreement

Reuters
·
May 19

Trendlines portfolio firm ElastiMed signs US distribution deal for MyoSleeve device

Reuters
·
May 18

Trendlines Group - U.S. Partner to Distribute Elastimed's FDA-Cleared Myosleeve Device

THOMSON REUTERS
·
May 18

Trendlines Group - Agreement Includes Minimum Purchase Commitments and Growth Support for Elastimed

THOMSON REUTERS
·
May 18

Trendlines Group - Elastimed Enters Strategic U.S. Distribution Agreement for Wearable Compression Device

THOMSON REUTERS
·
May 18

Trendlines answers shareholder questions ahead of April 16 AGM

Reuters
·
May 14

Trendlines, Controlling Shareholder to Invest Combined $1.4 Million in Portfolio Firms

MT Newswires
·
May 12

Trendlines says LH related firms invest USD 600,000 in Vensica round

Reuters
·
May 11

The Trendlines Drug Secures US FDA Nod for Phase 2 Bladder Treatment Trial; Shares Surge 5%

MT Newswires
·
May 05

Trendlines portfolio company Vensica wins FDA IND clearance for Phase 2 OAB trial

Reuters
·
May 04

Trendlines portfolio firm Celleste unveils milk chocolate bars using cell-cultured cocoa butter

Reuters
·
Apr 21